Antibiotic resistance: who will pay the bills?
作者信息
Zaoutis Theoklis E
出版信息
Clin Infect Dis. 2009 Oct 15;49(8):1185-6. doi: 10.1086/605631.
Abstract
摘要
相似文献
1
Antibiotic resistance: who will pay the bills?抗生素耐药性：谁来买单？
Clin Infect Dis. 2009 Oct 15;49(8):1185-6. doi: 10.1086/605631.
2
The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs.抗菌药物耐药性与患者预后之间的关系：死亡率、住院时间和医疗费用。
Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9. doi: 10.1086/499406.
3
Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.芝加哥一家教学医院中耐抗菌药物感染的医院及社会成本：对抗生素管理的启示
Clin Infect Dis. 2009 Oct 15;49(8):1175-84. doi: 10.1086/605630.
4
Novel Programs and Discoveries Aim to Combat Antibiotic Resistance.新型计划与发现旨在对抗抗生素耐药性。
JAMA. 2015;313(24):2411-3. doi: 10.1001/jama.2015.4738.
5
Antibiotic resistance as a major public health concern: epidemiology and economic impact.抗生素耐药性作为一个主要的公共卫生问题：流行病学与经济影响。
Ann Ig. 2015 May-Jun;27(3):562-79. doi: 10.7416/ai.2015.2048.
6
Economic burden of antibiotic resistance: how much do we really know?抗生素耐药性的经济负担：我们到底了解多少？
Clin Microbiol Infect. 2014 Oct;20(10):973-80. doi: 10.1111/1469-0691.12798. Epub 2014 Nov 7.
7
Economics of antibiotic resistance.抗生素耐药性经济学
Expert Rev Anti Infect Ther. 2008 Aug;6(4):523-39. doi: 10.1586/14787210.6.4.523.
8
Antimicrobial Resistance: Threat, consequences and options.抗微生物药物耐药性：威胁、后果与应对措施
Natl Med J India. 2018 May-Jun;31(3):133-135. doi: 10.4103/0970-258X.255752.
9
The negative impact of antibiotic resistance.抗生素耐药性的负面影响。
Clin Microbiol Infect. 2016 May;22(5):416-22. doi: 10.1016/j.cmi.2015.12.002. Epub 2015 Dec 17.
10
[Strategy for empirical antibiotic therapy re-evaluation: do you have to change a successful therapy?].[经验性抗生素治疗重新评估策略：是否必须改变成功的治疗方案？]
Ann Fr Anesth Reanim. 2004 Jun;23(6):654-7. doi: 10.1016/j.annfar.2004.05.004.
本文引用的文献
1
Clinical and economic burden of antimicrobial resistance.抗菌药物耐药性的临床和经济负担。
Expert Rev Anti Infect Ther. 2008 Oct;6(5):751-63. doi: 10.1586/14787210.6.5.751.
2
The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance.美国国立过敏与传染病研究所针对抗菌药物耐药性的研究议程。
J Infect Dis. 2008 Apr 15;197(8):1087-93. doi: 10.1086/533451.
3
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.抗生素耐药性感染的流行：美国传染病学会向医学界发出的行动呼吁。
Clin Infect Dis. 2008 Jan 15;46(2):155-64. doi: 10.1086/524891.
4
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.美国传染病学会和美国医疗保健流行病学学会关于制定机构计划以加强抗菌药物管理的指南。
Clin Infect Dis. 2007 Jan 15;44(2):159-77. doi: 10.1086/510393. Epub 2006 Dec 13.
5
The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs.抗菌药物耐药性与患者预后之间的关系：死亡率、住院时间和医疗费用。
Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9. doi: 10.1086/499406.
6
The impact of antimicrobial resistance on health and economic outcomes.抗菌药物耐药性对健康和经济成果的影响。
Clin Infect Dis. 2003 Jun 1;36(11):1433-7. doi: 10.1086/375081. Epub 2003 May 16.
7
Bacterial resistance: origins, epidemiology, and impact.细菌耐药性：起源、流行病学及影响
Clin Infect Dis. 2003 Jan 15;36(Suppl 1):S11-23. doi: 10.1086/344654.
8
Development and spread of bacterial resistance to antimicrobial agents: an overview.细菌对抗菌药物耐药性的产生与传播：概述
Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S108-15. doi: 10.1086/321834.
9
Health and economic impacts of antimicrobial resistance.抗菌药物耐药性对健康和经济的影响。
Rev Infect Dis. 1987 Nov-Dec;9(6):1065-78. doi: 10.1093/clinids/9.6.1065.
Zotero 插件